News & Articles

Integrated pre-clinical platform to accelerate therapeutic development

Opens access to early biologics discovery and academic labs with flexible 4-8 channel throughputs and best-in-class pricing

By maximizing data quality, RMX GC columns generate more compliant results — even for the most challenging semivolatiles — so accurate results are reported, and samples keep moving through the lab

For fast, non-destructive at-line testing in pharmaceutical and industrial environments

Amsbio offers two types of AAV reference materials – full and empty for a wide range of serotypes

New collaboration empowers customers with sequence-perfect constructs as long as 50 kb

TRRS leverages the faster interaction time of Raman scattering to distinguish the Raman signal from the fluorescence background

New handheld decapper boosts speed and consistency of 48-format tube handling

Registry developed to advance real-world evidence in treatment outcomes

The new model features a slim ergonomic handle, a rotating finger rest, and a User Adjustment mechanism that allows reversible fine-tuning to accommodate varying liquids, temperatures, and tip styles

MOBILion Systems has shown how its proprietary PAMAF™ mode of high‑resolution ion mobility can reshape mass‑spectrometry‑based proteomics

Supplement was developed through collaboration between Ajinomoto Co., Inc. (Tokyo, Japan) and its US-based consolidated subsidiary, Forge Biologics

New, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks

New services make patient-specific stem cells more accessible for drug discovery and disease studies

Fast, gentle, and highly specific glycoprotein labeling compatible with downstream immunofluorescence, enabled by next-generation aminooxy chemistry

Availability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences

Froedtert Hospital results reinforce growing real-world evidence that IntelliSep is a transformative tool for suspected infections in emergency departments

Next generation vacuum pump for reliable inline degassers

The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care

Phase 1 trial in aggressive brain cancer (glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platform

Gilboa-based formulations for wheat in Great Britain expected in 2027, followed by broader European launches in 2029

Scalable automation for low-viscosity samples